Women's Health: Mayo Clinic Radio
On the next Mayo Clinic Radio, we’ll discuss a long list of items regarding women’s health with Stephanie Faubion, M.D.  Of course our bodies are constantly changing, but what can be done about the symptoms accompany aging, especially for women?  We’ll touch on hot flashes, night sweats and new options for hormone therapy.  Plus, just what is perimenopause? [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 25, 2014 Category: Databases & Libraries Source Type: news

NICE rejects Zytiga as prostate cancer treatment before chemotherapy
In its final draft guidance, NICE has not recommended abiraterone for prostate cancer in people who received hormone therapy (androgen deprivation) but whose disease has spread, who have few symptoms and when chemotherapy would not yet have been given. (Source: Pharmacy Europe)
Source: Pharmacy Europe - August 15, 2014 Category: Drugs & Pharmacology Authors: ebercott Tags: *** Editor's Pick Oncology abiraterone janssen Latest News nice prostate cancer Zytiga Source Type: news

NSAID Use May Reduce Breast Cancer Recurrence in ObeseNSAID Use May Reduce Breast Cancer Recurrence in Obese
Postmenopausal women treated with hormone therapy for estrogen-receptor-positive breast cancer who are overweight or obese had a lower recurrence rate if they also took NSAIDs. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 14, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

NSAIDs benefit overweight breast cancer patients, study finds
(University of Texas at Austin) Researchers have determined that postmenopausal overweight or obese breast cancer patients receiving hormone therapy as part of their treatment and who use nonsteroidal anti-inflammatory drugs such as aspirin or ibuprofen have significantly lower breast cancer recurrence rates and a sizable delay in time to cancer recurrence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 14, 2014 Category: Cancer & Oncology Source Type: news

Menopause: Hormone Therapy Does Not Slow AtherosclerosisMenopause: Hormone Therapy Does Not Slow Atherosclerosis
In newly menopausal women, low-dose hormone therapy did not affect carotid artery intima-media thickness or coronary artery calcium, but it did improve lipids and insulin resistance. Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 31, 2014 Category: Cardiology Tags: Ob/Gyn & Women ' s Health News Source Type: news

Early Hormone Therapy May Be Safe for Women's Hearts
Title: Early Hormone Therapy May Be Safe for Women's HeartsCategory: Health NewsCreated: 7/28/2014 5:36:00 PMLast Editorial Review: 7/29/2014 12:00:00 AM (Source: MedicineNet Womens Health General)
Source: MedicineNet Womens Health General - July 29, 2014 Category: OBGYN Source Type: news

Early Hormone Therapy May Be Safe for Women's Hearts
HRT, hormone therapy, early hormone therapy (Source: WebMD Health)
Source: WebMD Health - July 29, 2014 Category: Consumer Health News Source Type: news

No Reduction in Atherosclerosis Progression with Menopausal Hormone Therapy (FREE)
By Larry Husten Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Menopausal hormone therapy may have favorable effects on some cardiovascular risk factors, but it doesn't reduce the progression of atherosclerosis, according to an Annals of Internal Medicine study.Over … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 29, 2014 Category: Primary Care Source Type: news

Hormone Therapy At Menopause Fails To Halt Heart Disease Progression
More than a decade ago the Women's Health Study produced surprising and important results when it showed that broad use of hormone replacement therapy did not reduce cardiovascular risk in post-menopausal women. But the study also led to speculation  that hormone therapy  might be beneficial when delivered closer to the time of menopause. Now a study published in Annals of Internal Medicine shows that menopausal hormone therapy (MHT) may have some favorable effects on some cardiovascular risk factors but it does not reduce the progression of atherosclerosis. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 28, 2014 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

Early Hormone Therapy May Be Safe for Women's Hearts
Hormone replacement started soon after menopause wasn't linked to hardening of the arteries in study Source: HealthDay Related MedlinePlus Pages: Heart Disease in Women, Hormone Replacement Therapy, Menopause (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 28, 2014 Category: Consumer Health News Source Type: news

News from Annals of Internal Medicine tip sheet July 29, 2014
(American College of Physicians) The July 29, 2014, issue of Annals of Internal Medicines includes articles titled: 'Early menopausal hormone therapy shows no effect on atherosclerosis progression'; 'More information needed to determine the effectiveness of different types of decision'; and 'Safety lapses at government labs raise serious bioterror concerns.' (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 28, 2014 Category: Infectious Diseases Source Type: news

Monday's Housecall
THIS WEEK'S TOP STORIES Menopause hormone therapy: Pros and cons Hormone therapy can provide effective relief from menopause symptoms. Talk with your doctor to weigh your personal risks and benefits. Best sunscreen: Understand sunscreen options With so many types of sunscreen out there, it can be hard to know which to choose. This Q&A with [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 28, 2014 Category: Databases & Libraries Source Type: news

Hormones after breast cancer: Not fuel for the fire after all?
(Parsemus Foundation) Study highlights beneficial effects of non-oral hormone therapy on cardiac and bone outcomes, tumor reduction, and overall health in postmenopausal breast cancer mouse model. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 23, 2014 Category: Global & Universal Source Type: news

Growth Hormone in Adults With Growth Hormone DeficiencyGrowth Hormone in Adults With Growth Hormone Deficiency
What are the long-term effects of growth hormone therapy on risk of cardiovascular disease, fractures, cancer, and stroke? Clinical Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 18, 2014 Category: Endocrinology Tags: Diabetes & Endocrinology Journal Article Source Type: news

Quiz: Hormone Therapy in Menopausal WomenQuiz: Hormone Therapy in Menopausal Women
How much do you know about the benefits and risks of HT for menopausal women? Test your knowledge with this quiz. Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 18, 2014 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Interactive Quiz Source Type: news

New method may allow breast cancer drug to be given through skin
Endoxifen, a drug that has proven effective in the prevention and treatment of breast cancer, but with serious side-effects, may be delivered effectively through the skin using a new topical drug-delivery system. Endoxifen, one of the most commonly used hormone therapy for breast cancer, has also been shown to prevent the disease. However, taken orally, the drug can cause side-effects such as hot flashes and vaginal atrophy, along with increased risk of endometrial cancer and stroke, that leave it wanting as a routine method of chemoprevention. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 11, 2014 Category: Science Source Type: news

Lessons From WHI, Part 3: Cost-EffectivenessLessons From WHI, Part 3: Cost-Effectiveness
Drs. Black and Jackson discuss a new cost analysis that demonstrates the value of the WHI hormone therapy study. Medscape Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 8, 2014 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Lessons From the WHI -- Part 1: Hormone TherapyLessons From the WHI -- Part 1: Hormone Therapy
In part 1 of Dr. Black's interview with Dr. Rebecca Jackson, they review the landmark Women's Health Initiative findings on hormone therapy. Medscape Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 8, 2014 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Lessons From the WHI, Part 1: Hormone TherapyLessons From the WHI, Part 1: Hormone Therapy
In part 1 of Dr. Black's interview with Dr. Rebecca Jackson, they review the landmark Women's Health Initiative findings on hormone therapy. Medscape Cardiology (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - July 8, 2014 Category: OBGYN Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

HRT Treatments / NHR Hormone Therapy and Weight Loss Plans Announces...
HRT Treatments / NHR Hormone Therapy and Weight Loss Plans now offers home progesterone testing kits and evaluation, offering simple hormone testing done safely from each client’s home.(PRWeb July 03, 2014)Read the full story at http://www.prweb.com/releases/hormone-testing/progesterone-cream/prweb11993572.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 3, 2014 Category: Pharmaceuticals Source Type: news

Largest Study to Date: Transgender Hormone Treatment Safe Largest Study to Date: Transgender Hormone Treatment Safe
A multicenter study of more than 1500 patients receiving cross-sex hormone therapy for at least a year showed that most side effects were minor, providing reassurance on safety. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 2, 2014 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

PSMA-based imaging traces even treatment-resistant prostate cancer
(Society of Nuclear Medicine) Anti-androgen hormonal therapy, also called chemical castration, can be an important defense against further disease progression for patients with prostate cancer that has traveled and grown in other areas, or metastasized -- but some cases simply do not respond to this treatment. A groundbreaking molecular imaging agent has been developed to help clinicians find as much cancer as possible, whether it is responding favorably or not, in an effort to improve clinical decision making for these patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 9, 2014 Category: Cancer & Oncology Source Type: news

The 5 Types of Breast Cancer Treatment Options
After your breast cancer has been diagnosed, your healthcare team will recommend treatment. There are five standard treatment options for breast cancer: surgery, chemotherapy, radiation, targeted biologic, and hormonal therapy. Learn about each one, and how a decision on which is right for you is made. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - June 6, 2014 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news

ASCO: Oreronel Fails to Boost Prostate Cancer Survival
CHICAGO (MedPage Today) -- The novel anti-androgen orteronel delayed progression in chemotherapy-naive metastatic prostate cancer refractory to standard hormone therapy, but without a survival benefit. (Source: MedPage Today Urology)
Source: MedPage Today Urology - June 5, 2014 Category: Urology & Nephrology Source Type: news

ASCO: Orteronel Fails to Boost Prostate Cancer Survival
CHICAGO (MedPage Today) -- The novel anti-androgen orteronel delayed progression in chemotherapy-naive metastatic prostate cancer refractory to standard hormone therapy, but without a survival benefit. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 5, 2014 Category: Geriatrics Source Type: news

ASCO: Combo Hormone Tx Promising in Prostate Cancer
CHICAGO (MedPage Today) -- A combination attack on androgens in metastatic prostate cancer resistant to initial hormone therapy drove down testosterone levels and appeared safe, according to a proof of concept study. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 3, 2014 Category: Primary Care Source Type: news

Practice-Changing Results for Metastatic Prostate CancerPractice-Changing Results for Metastatic Prostate Cancer
For patients with metastatic hormone-sensitive prostate cancer, upfront chemotherapy with docetaxel, given at the same time as hormone therapy, prolongs survival, new research shows. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

10 Years of Hormones for Breast Cancer, ASCO Says (CME/CE)
(MedPage Today) -- All women with hormone receptor-positive breast cancer should have the option to continue adjuvant hormonal therapy for as long as a decade, according to an updated guideline from the American Society of Clinical Oncology. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - May 28, 2014 Category: Geriatrics Source Type: news

SNRI Equal to Hormones for Hot Flush Tx
(MedPage Today) -- A low dose of the serotonin-norepinephrine reuptake inhibitor venlafaxine (Effexor) appeared roughly as good as hormonal therapy to ease hot flushes in menopause, a randomized trial showed. (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 27, 2014 Category: Psychiatry Source Type: news

Fighting cancer with dietary changes
Calorie restriction during treatment for breast cancer changes cellular programming in a way that lowers the chance of metastases in mice. Breast cancer patients are often treated with hormonal therapy to block tumor growth, and steroids to counteract the side effects of chemotherapy. However, both treatments can cause a patient to have altered metabolism which can lead to weight gain. In fact, women gain an average of 10 pounds in their first year of treatment. Recent studies have shown that too much weight makes standard treatments for breast cancer less effective, and those who gain weight during treatment have worse ca...
Source: ScienceDaily Headlines - May 26, 2014 Category: Science Source Type: news

Stage 4 prostate cancer hormone therapy
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - May 20, 2014 Category: Consumer Health News Source Type: news

Treatment of Gastroenteropancreatic Neuroendocrine TumorsTreatment of Gastroenteropancreatic Neuroendocrine Tumors
Neuroendocrine tumor treatment now includes hormone therapy, chemotherapy, and targeted biologic therapy. Endocrine Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 15, 2014 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy: Study
Title: Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy: StudyCategory: Health NewsCreated: 5/14/2014 5:36:00 PMLast Editorial Review: 5/15/2014 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 15, 2014 Category: Cancer & Oncology Source Type: news

A Study on Prostate Cancer Relapses Suggests That Hormone Therapy Can Wait
Such therapy can cause side effects like hot flashes, loss of libido and weakening of muscles and bones. (Source: NYT Health)
Source: NYT Health - May 15, 2014 Category: Consumer Health News Authors: By ANDREW POLLACK Tags: Pfizer Inc PFE NYSE Roche Holding A G RHHBY Other OTC Prostate Cancer Bristol Myers Squibb Company BMY NYSE Tests (Medical) Source Type: news

Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy: Study
Even if PSA levels are rising, postponing the treatment may boost quality of life without lowering survival (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 15, 2014 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Endocrinology, Family Medicine, Nursing, Oncology, Pharmacy, Reproductive Medicine, News, Source Type: news

Some Prostate Cancer Patients Might Safely Delay Hormonal Therapy
Even if PSA levels are rising, postponing the treatment may boost quality of life without lowering survival Source: HealthDay Related MedlinePlus Page: Prostate Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 14, 2014 Category: Consumer Health News Source Type: news

“A Study on Prostate Cancer Relapses Suggests that Hormone Therapy Can Wait,”
This article features commentary from physicians at Dana-Farber/Brigham and Women’s Cancer Center and Moffitt Cancer Center-two of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - May 14, 2014 Category: Cancer & Oncology Source Type: news

Early menopause linked to mental decline
Conclusion This study found a link between premature menopause and memory problems. Strengths of the study include the large number of participants and the fact they were followed prospectively, which reduces the chance of bias. However, as it was a cohort study, it cannot prove that the memory problems were caused by their premature menopause. The researchers analysed the results, taking multiple factors into consideration. Patient recall, the age of menopause and the type and duration of taking any hormonal therapy may also have been inaccurate. A further limiting factor in this study is that it commenced when women were...
Source: NHS News Feed - May 8, 2014 Category: Consumer Health News Tags: Neurology Lifestyle/exercise Cancer Source Type: news

Combined hormone therapy clinical trial yields massive economic return
The overall economic return from a combined hormone therapy clinical trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published. "The motivation for the first WHI trial was to see if we could prevent heart disease, the number one killer of women. That's why we did it -- the economics never occurred to me," said the lead investigator. What these findings underscore is the significant role clinical trials play in science and the importance of continuing to find ways to strategically invest public res...
Source: ScienceDaily Headlines - May 6, 2014 Category: Science Source Type: news

WHI reports $37.1B economic return on combined hormone therapy clinical trial
(Fred Hutchinson Cancer Research Center) The overall economic return from the Women's Health Initiative E+P trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 5, 2014 Category: Cancer & Oncology Source Type: news

WHI reports $37.1 billion economic return on combined hormone therapy clinical trial
(Fred Hutchinson Cancer Research Center) The overall economic return from the Women's Health Initiative E+P trial indicates that changes in practice stemming from the trial provided a net economic return of $37.1 billion over the 10-year period since the main findings were published. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 5, 2014 Category: Cancer & Oncology Source Type: news

HRT Treatments / Diet Doc Hormone Replacement & Weight Loss Plans...
Diet Doc now offers patients a great new way to test for hormonal imbalance that may be causing weight gain, or hindering weight loss, with new Weight Management Profile hormone testing kits, done...(PRWeb April 25, 2014)Read the full story at http://www.prweb.com/releases/hormone-therapy/weight-loss/prweb11795003.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 26, 2014 Category: Pharmaceuticals Source Type: news

HRT Treatments / Diet Doc Hormone Therapy & Weight Loss Plans...
Diet Doc now offers hormone replacement therapy, utilizing bio-identical hormones to relieve symptoms of hormonal imbalance. Test kits are sent directly to the patient’s home, and results are...(PRWeb April 19, 2014)Read the full story at http://www.prweb.com/releases/hormone-replacement/hormonal-imbalance/prweb11777897.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 19, 2014 Category: Pharmaceuticals Source Type: news

Six months hormone therapy in addition to radiotherapy improves prostate cancer survival (Medical Xpress, 7 April 2014)
A French study presented at the 33rd conference of the European Society for Radiotherapy and Oncology in Vienna assessed prostate cancer survival rates for men undergoing radiotherapy combined with androgen deprivation therapy. Full article (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 8, 2014 Category: Endocrinology Source Type: news

Hormone therapy linked to lower non-Hodgkin lymphoma risk
Menopausal hormone therapy use is linked to a lower risk of B-cell non-Hodgkin lymphoma, research has found. "The connection between lymphomas and menopausal hormone therapy use hinges on understanding the disease's biology and the window of susceptibility," the lead researcher said. "Hormone therapy is of interest because the loss of estrogen coupled with aging in women result in decreased immune function, which can elevate risk of non-Hodgkin lymphoma." (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 7, 2014 Category: Science Source Type: news

Six months hormone therapy in addition to radiotherapy improves prostate cancer survival
(European Society for Radiotherapy and Oncology (ESTRO)) Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research to be presented at the 33rd conference of the European Society for Radiotherapy and Oncology in Vienna. The findings are expected to change clinical practice. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 6, 2014 Category: Cancer & Oncology Source Type: news

Intimacy and Sex After Cancer Treatment is Over
Intimacy and sex after cancer treatment is over Emotions can have a strong effect on your desire for sex due to anxiety, fears and physical changes during and after cancer treatment. Be patient as you heal. Hormone therapy for breast cancer Get the facts about this treatment for breast cancers that are sensitive to hormones. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 24, 2014 Category: Databases & Libraries Source Type: news

Some Breast Cancers Require Longer Tx
(MedPage Today) -- Breast cancers with high-level estrogen sensitivity had a significantly greater risk of late recurrence, possibly indicating a need for more than 5 years of adjuvant hormonal therapy, British investigators reported. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 21, 2014 Category: Primary Care Source Type: news

Extended hormone therapy may help some women with ER+ breast cancer
Genetic analyses of results from 1125 postmenopausal women being treated for oestrogen responsive breast cancer have shown that some of them are more likely than others to have a late recurrence of their cancer and might benefit from ten years of hormone therapy rather than five. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 21, 2014 Category: Consumer Health News Tags: Breast Cancer Source Type: news